Jonathan Solomon - 29 Mar 2022 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Solomon
Issuer symbol
PHGE
Transactions as of
29 Mar 2022
Net transactions value
$0
Form type
4
Filing time
31 Mar 2022, 17:25:30 UTC
Previous filing
30 Jul 2021
Next filing
24 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Common Stock Options - Right to Buy Award $0 +205,000 $0.000000 205,000 29 Mar 2022 Common Stock 205,000 $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years.